Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Consumer Services
/
Allurion Technologies
ALUR
Allurion Technologies
Global Obesity Trends And Telemedicine Will Accelerate Non-invasive Weight Loss
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 4 Analysts
Published
19 Aug 25
Updated
19 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
US$16.00
85.9% undervalued
intrinsic discount
19 Aug
US$2.25
Loading
1Y
-87.1%
7D
-12.8%
Author's Valuation
US$16.0
85.9% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
US$16.0
85.9% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-76m
64m
2021
2022
2023
2024
2025
2026
2027
2028
Revenue US$43.2m
Earnings US$5.0m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
-1.33%
Consumer Services revenue growth rate
0.42%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
12.32%
Calculation
US$5.04m
Earnings '28
x
73.66x
PE Ratio '28
=
US$371.45m
Market Cap '28
US$371.45m
Market Cap '28
/
16.38m
No. shares '28
=
US$22.67
Share Price '28
US$22.67
Share Price '28
Discounted to 2025 @ 12.32% p.a.
=
US$16.00
Fair Value '25